The LEGACy study: a European and Latin American consortium to identify risk factors and molecular phenotypes in gastric cancer to improve prevention strategies and personalized clinical decision making globally.
van Schooten TS, Derks S, Jiménez-Martí E, Carneiro F, Figueiredo C, Ruiz E, Alsina M, Molero C, Garrido M, Riquelme A, Caballero C, Lezcano E, O'Connor JM, Esteso F, Farrés J, Mas JM, Lordick F, Vogt J, Cardone A, Girvalaki C, Cervantes A, Fleitas T; members of LEGACy consortium.
van Schooten TS, et al. Among authors: jimenez marti e.
BMC Cancer. 2022 Jun 13;22(1):646. doi: 10.1186/s12885-022-09689-9.
BMC Cancer. 2022.
PMID: 35692051
Free PMC article.